28/09/2023
Swiss PharmaCan, a pioneering member of the SwissBiotech Group and a leader in longevity science and healthcare, is forging ahead with an incredible opportunity for MyCell Technology research in Thailand. Michel Fässler, CEO of Swiss PharmaCan had the honour of meeting with the esteemed officials from the Ministry of Health in Thailand and to discuss this groundbreaking initiative.
Swiss PharmaCan, known for its cutting-edge advancements in the field of longevity, prevention and regeneration, is now extending its expertise and collaborative efforts to Thailand. This strategic move aims to propel research and development in the realms of ageing biology, nutraceuticals, and therapies related to ageing control, regeneration, and prevention.
Swiss BioTech Group, at the forefront of promoting healthy longevity for all, is committed to leveraging scientific research to enhance the quality of life and well-being across the globe. Through innovative partnerships and a commitment to advancing scientific understanding, we are dedicated to making a positive impact on society by driving progress in the realm of health and longevity.
Explore now the most innovative solutions for prevention, regeneration and healthcare: www.swisspharmacan.ch